JP2006516019A - モリンダ・シトリフォリアの抗真菌効果 - Google Patents
モリンダ・シトリフォリアの抗真菌効果 Download PDFInfo
- Publication number
- JP2006516019A JP2006516019A JP2004506834A JP2004506834A JP2006516019A JP 2006516019 A JP2006516019 A JP 2006516019A JP 2004506834 A JP2004506834 A JP 2004506834A JP 2004506834 A JP2004506834 A JP 2004506834A JP 2006516019 A JP2006516019 A JP 2006516019A
- Authority
- JP
- Japan
- Prior art keywords
- morinda citrifolia
- juice
- processed
- formulation
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
科学的にはモリンダ・シトリフォリアL.(Morinda citrifolia)として知られるインディアンマルベリーもしくはノニ植物は,低木,すなわち小または中サイズの高さ3−10メートルの木である。これは世界中の熱帯の海岸領域で成長する。この植物は,西南アジアに自生し,初期にインドから東ポリネシアの広い領域に広がった。これは,天然に無作為的に成長し,農園および小規模の個々の成長小区画で栽培されてきた。モリンダ・シトリフォリアは幾分丸い枝,および常緑の,対生の(または擬似互生の),暗色の,光沢のある,波状の,葉脈の突起した葉を有する。この葉は両末端がとがったやや楕円形であり,長さ10−30cm,幅5−15cmである。
本発明は,インディアンマルベリー植物に由来する1またはそれ以上の加工されたモリンダ・シトリフォリア製品を用いて処方された天然物医薬組成物を提供することにより,真菌および他の微生物の阻害剤を進歩させるものである。モリンダ・シトリフォリアは,患者のインビボ治療に適した種々のキャリアまたは天然物医薬組成物中に組み込まれる。例えば,阻害剤は,適当かつ指示されるように,摂取し,注射し,静脈内に導入し,または他の方法により体内に導入することができる。
成分 重量パーセント
モリンダ・シトリフォリアピューレ果汁または果汁 100%
処方2
成分 重量パーセント
モリンダ・シトリフォリア果汁 85〜99.99%
水 0.1〜15%
処方3
成分 重量パーセント
モリンダ・シトリフォリア果汁 85〜99.99%
非モリンダ・シトリフォリア系果汁 0.1〜15%
処方4
成分 重量パーセント
モリンダ・シトリフォリア果汁 50〜90%
水 0.1〜50%
非モリンダ・シトリフォリア系果汁 0.1〜30%
処方5
成分 重量パーセント
モリンダ・シトリフォリアピューレ果汁 85〜99.9%
水 0.1〜15%
処方6
成分 重量パーセント
モリンダ・シトリフォリアピューレ果汁 85〜99.99%
非モリンダ・シトリフォリア系果汁 0.1〜15%
処方7
成分 重量パーセント
モリンダ・シトリフォリアピューレ果汁 50〜90%
水 0.1〜50%
非モリンダ・シトリフォリア系果汁 0.1〜30%
処方8
成分 重量パーセント
モリンダ・シトリフォリア食物繊維 0.1〜30%
水 1〜99.9%
非モリンダ・シトリフォリア系果汁 1〜99.9%
処方9
成分 重量パーセント
モリンダ・シトリフォリア食物繊維 0.1〜30%
水 1〜99.9%
モリンダ・シトリフォリア果汁またはピューレ果汁 1〜99.9%
処方10
成分 重量パーセント
モリンダ・シトリフォリア油 0.1〜30%
キャリア媒体 70〜99.9%
他の成分 1〜95%
処方11
成分 重量パーセント
モリンダ・シトリフォリア製品 10〜80%
キャリア媒体 20〜90%
処方12
成分 重量パーセント
モリンダ・シトリフォリア製品 5〜80%
キャリア媒体 20〜95%
処方13
成分 重量パーセント
モリンダ・シトリフォリア油または油抽出物 0.1〜20%
キャリア媒体 20〜90%
処方14
成分 重量パーセント
モリンダ・シトリフォリアピューレ果汁または果汁 0.1〜80%
モリンダ・シトリフォリア油 0.1〜20%
キャリア媒体 20〜90%
処方15
成分 重量パーセント
モリンダ・シトリフォリアピューレ果汁濃縮物 100%
または果汁濃縮物
処方16
成分 重量パーセント
モリンダ・シトリフォリアピューレ果汁濃縮物 85〜99.99%
または果汁濃縮物
水 0.1〜15%
処方17
成分 重量パーセント
モリンダ・シトリフォリアピューレ果汁または果汁画分 100%
処方18
成分 重量パーセント
モリンダ・シトリフォリア果汁画分 85〜99.99%
水 0.1〜15%
処方19
成分 重量パーセント
モリンダ・シトリフォリア果汁画分 85〜99.99%
非モリンダ・シトリフォリア系果汁 0.1〜15%
処方20
成分 重量パーセント
モリンダ・シトリフォリア果汁画分 50〜90%
水 0.1〜50%
非モリンダ・シトリフォリア系果汁 0.1〜30%
処方21
成分 重量パーセント
モリンダ・シトリフォリアピューレ果汁画分 85〜99.9%
水 0.1〜15%
処方22
成分 重量パーセント
モリンダ・シトリフォリアピューレ果汁画分 85〜99.9%
非モリンダ・シトリフォリア系果汁 0.1〜15%
Claims (13)
- 哺乳動物中で真菌および微生物の成長を阻害するための処方であって,約0.01−50重量%のケルセチンを含むことを特徴とする処方。
- 前記加工された処方が,前記ケルセチンと相乗的に作用して前記真菌および微生物の成長を阻害する追加の活性成分としてルチンをさらに含む,請求項1記載の処方。
- 前記ルチンが約0.1−10重量%の量で存在する,請求項2記載の方法。
- 前記処方が,経口,経皮,前記感染部位への注射,静脈内,および全身からなる群より選択される方法により投与される,請求項1記載の処方。
- 哺乳動物中で真菌および微生物の成長を阻害するための処方であって,0.01−10重量%のモリンダ・シトリフォリアのn−ヘキサン画分を含む経口天然物医薬組成物を含む前記処方。
- 前記モリンダ・シトリフォリアの画分がモリンダ・シトリフォリアのCL2CL2画分を含む,請求項5記載の処方。
- 前記モリンダ・シトリフォリアの画分がモリンダ・シトリフォリアのETOAc画分を含む,請求項5記載の処方。
- 前記モリンダ・シトリフォリアの画分がモリンダ・シトリフォリアのn−BuOH画分を含む,請求項5記載の処方。
- 哺乳動物中で有害な真菌および微生物の活性を阻害する方法であって,
前記哺乳動物に,加工したモリンダ・シトリフォリア果汁を含み,さらに,ケルセチン,ルチン,n−ヘキサン,CL2CL2,ETOAc,およびn−BuOHからなる群より選択される1−10重量%の活性成分を含む,少なくとも3オンスの天然物医薬処方を朝の空腹時に経口投与し;
前記哺乳動物に,少なくとも3オンスの前記天然物医薬処方を夜の就寝前の空腹時に経口投与し;そして
すべての有害な真菌および微生物が破壊されるまで前記経口投与の工程を毎日繰り返す,
の各工程を含む方法。 - 哺乳動物中で真菌および微生物の活性を阻害する方法であって,
内服用組成物を前記哺乳動物に全身的に導入する工程を含み,前記内服用組成物は,
約10−80重量%の量で存在する加工したモリンダ・シトリフォリア製品;および
約20−90重量%の量で存在するキャリア媒体
を含むことを特徴とする方法。 - 前記加工したモリンダ・シトリフォリア製品が,加工したモリンダ・シトリフォリア果汁,
加工したモリンダ・シトリフォリアピューレ果汁,加工したモリンダ・シトリフォリア食物繊維,加工したモリンダ・シトリフォリア油,加工したモリンダ・シトリフォリア果汁濃縮物,加工したモリンダ・シトリフォリアピューレ果汁濃縮物,および加工したモリンダ・シトリフォリア油抽出物からなる群より選択される,請求項10記載の方法。 - 哺乳動物の身体中で真菌および微生物の活性を制御する方法であって,内服用組成物を前記哺乳動物に全身的に導入する工程を含み,前記内服用組成物は,約0.1−100重量%の量で存在する加工したモリンダ・シトリフォリア製品を含むことを特徴とする方法。
- 約0.1−100重量%の量で存在する加工したモリンダ・シトリフォリアを含む,抗真菌および抗微生物天然物医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38224602P | 2002-05-21 | 2002-05-21 | |
US10/439,596 US7048952B2 (en) | 2002-05-21 | 2003-05-16 | Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice |
PCT/US2003/015912 WO2003099310A1 (en) | 2002-05-21 | 2003-05-21 | Antifungal effects of morinda citrifolia |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006516019A true JP2006516019A (ja) | 2006-06-15 |
Family
ID=29586951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004506834A Pending JP2006516019A (ja) | 2002-05-21 | 2003-05-21 | モリンダ・シトリフォリアの抗真菌効果 |
Country Status (6)
Country | Link |
---|---|
US (2) | US7048952B2 (ja) |
EP (1) | EP1505996A1 (ja) |
JP (1) | JP2006516019A (ja) |
AU (1) | AU2003233606A1 (ja) |
CA (1) | CA2486606A1 (ja) |
WO (1) | WO2003099310A1 (ja) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040192761A1 (en) * | 2003-03-25 | 2004-09-30 | Palu Afa Kehaati | Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor |
US20110217394A1 (en) * | 2000-12-05 | 2011-09-08 | Brett Justin West | Iridoid Based Formulations |
US8574642B2 (en) | 2000-12-05 | 2013-11-05 | Tahitian Noni International, Inc. | Antiviral Morinda citrifolia L. based formulations and methods of administration |
US20110171333A1 (en) * | 2000-12-05 | 2011-07-14 | Bryant Wadsworth | Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products |
US6855345B2 (en) * | 2001-11-02 | 2005-02-15 | Morinda, Inc. | Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions |
US20120237626A9 (en) * | 2000-12-05 | 2012-09-20 | Palu Afa Kehaati | Profiles of lipid proteins and inhibiting HMG-CoA reductase |
US8652546B2 (en) | 2007-09-06 | 2014-02-18 | Tahitian Noni International, Inc. | Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals |
US8790727B2 (en) | 2000-12-05 | 2014-07-29 | Tahitian Noni International, Inc. | Morinda citrifolia and iridoid based formulations |
US20050181082A1 (en) * | 2002-05-21 | 2005-08-18 | Fumiyuki Isami | Morinda citrifolla based antifungal formulations and methods |
US20100215786A9 (en) * | 2000-12-05 | 2010-08-26 | Jensen Claude Jarkae | Morinda citrifolia enhanced lip treatment |
US20110160057A1 (en) * | 2001-11-14 | 2011-06-30 | Bryant Wadsworth | Morinda Citrifolia Based Antimicrobial Formulations |
US7442395B2 (en) * | 2002-11-14 | 2008-10-28 | Tahitian Noni International, Inc. | Formulation for treating candidiasis using Morinda citrifolia |
US20050106275A1 (en) * | 2003-05-02 | 2005-05-19 | Chen Su | Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells |
JP4073826B2 (ja) * | 2003-06-04 | 2008-04-09 | タヒチアン ノニ インターナショナル インコーポレーテッド | ヤエヤマアオキの抽出物を含む農業用活力剤 |
US20070259060A1 (en) * | 2003-08-12 | 2007-11-08 | Mian-Ying Wang | Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane |
US20050084551A1 (en) * | 2003-09-26 | 2005-04-21 | Jensen Claude J. | Morinda citrifolia-based oral care compositions and methods |
US20050158412A1 (en) * | 2004-01-05 | 2005-07-21 | Chen Su | Type II diabetes |
US20050260291A1 (en) * | 2004-03-10 | 2005-11-24 | Palu Afa K | Methods and compositions for reactivating acetylcholinesterase |
US20050202108A1 (en) * | 2004-03-10 | 2005-09-15 | Palu Afa K. | Methods and compositions for inhibiting angiotensin converting and chymase enzymes |
US20060204601A1 (en) * | 2005-03-09 | 2006-09-14 | Palu Afa K | Formulations and methods for preventing and treating substance abuse and addiction |
US20070122507A1 (en) * | 2005-05-26 | 2007-05-31 | Palu Afa K | Histone deacetylase and tumor necrosis factor converting enzyme inhibition |
US20060280818A1 (en) * | 2005-05-26 | 2006-12-14 | Palu Afa K | Nicotinic acetylcholine receptor antagonist |
US20070116836A1 (en) * | 2005-11-23 | 2007-05-24 | The Coca-Cola Company | High-Potency Sweetener Composition for Treatment and/or Prevention of Osteoporosis and Compositions Sweetened Therewith |
US20070116822A1 (en) * | 2005-11-23 | 2007-05-24 | The Coca-Cola Company | High-potency sweetener composition with saponin and compositions sweetened therewith |
US20070116831A1 (en) * | 2005-11-23 | 2007-05-24 | The Coca-Cola Company | Dental Composition with High-Potency Sweetener |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
US20070116825A1 (en) * | 2005-11-23 | 2007-05-24 | The Coca-Cola Company | Confection with High-Potency Sweetener |
CA2629556A1 (en) * | 2005-11-23 | 2007-07-19 | The Coca Cola Company | Synthetic sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses |
US20070184137A1 (en) * | 2005-11-29 | 2007-08-09 | Palu Afa K | Morinda Citrifolia L. Based Formulations for Inhibiting Matrix Metalloproteinase Enzymes |
US20070166417A1 (en) * | 2005-11-29 | 2007-07-19 | Palu Afa K | Formulation and Methods for Use of Morinda Citrifolia Seed Oil |
US20070154579A1 (en) * | 2005-11-29 | 2007-07-05 | Palu Afa K | Morinda Citrifolia Based Formulation And Methods For Weight Management |
WO2007084983A2 (en) * | 2006-01-20 | 2007-07-26 | Tahitian Noni International, Inc. | Morinda citrifolia enhanced products for administration to animal |
US20070281903A1 (en) * | 2006-05-04 | 2007-12-06 | Palu Afa K | Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX |
US8025910B2 (en) * | 2006-05-12 | 2011-09-27 | Tahitian Noni International, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
US8535741B2 (en) | 2006-05-12 | 2013-09-17 | Morinda, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
GB0611115D0 (en) * | 2006-06-06 | 2006-07-19 | Novabiotics Ltd | Compounds and their use |
US8507234B2 (en) * | 2006-06-16 | 2013-08-13 | Polymer Ventures, Inc. | Composition and methods for improving the production of fermentation operations |
BRPI0711999A2 (pt) * | 2006-06-16 | 2012-02-14 | Polymer Ventures Inc | método de aumento da produção de um composto orgánico e não terpeno e composição de aumento da velocidade de produção e/ou do rendimento de um composto orgánico não terpeno |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
US20080146444A1 (en) * | 2006-12-19 | 2008-06-19 | Polymer Ventures, Inc. | Method and compositions for improving plant growth |
US20080206368A1 (en) * | 2007-02-26 | 2008-08-28 | Mian-Ying Wang | Administration of Morinda Citrifolia L. Based Formulations to Increase Birth Rates |
US20080317890A1 (en) * | 2007-06-21 | 2008-12-25 | Claude Jarakae Jensen | Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical |
US20090011057A1 (en) * | 2007-07-05 | 2009-01-08 | Afa Kehaati Palu | Formulations and methods for inhibiting anaerobes, gram negative bacteria, protozoa and other microbial growth with morinda citrifolia l. enhanced formulations |
US20090053341A1 (en) * | 2007-08-21 | 2009-02-26 | Afa Kehaati Palu | Preventative and Treatment Effects of Morinda Citrifolia as an Aromatase Inhibitor |
US20090196944A1 (en) * | 2008-02-01 | 2009-08-06 | Brad Rawson | Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS |
US20110206786A1 (en) * | 2010-02-23 | 2011-08-25 | Brett Justin West | Acai and Iridoid Based Formulations |
CN102940290B (zh) * | 2012-11-27 | 2014-03-12 | 俞丹 | 一种诺尼果汁的制备方法 |
US9850512B2 (en) | 2013-03-15 | 2017-12-26 | The Research Foundation For The State University Of New York | Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield |
US9951363B2 (en) | 2014-03-14 | 2018-04-24 | The Research Foundation for the State University of New York College of Environmental Science and Forestry | Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6020388B2 (ja) * | 1974-07-18 | 1985-05-21 | エーザイ株式会社 | ビタミンe脂肪族カルボン酸エステルの合成法 |
US4543212A (en) * | 1978-01-19 | 1985-09-24 | Research Corporation Of The University Of Hawaii | Xeronine, a new alkaloid, useful in medical, food and industrial fields |
US4666606A (en) * | 1978-01-19 | 1987-05-19 | The Research Corporation Of The University Of Hawaii | Method for eliminating grease and odors from sewage systems |
US4409144A (en) * | 1978-01-19 | 1983-10-11 | Research Corporation Of The University Of Hawaii | Xeronine, a new alkaloid, useful in medical, food and industrial fields |
JPS5564504A (en) * | 1978-11-10 | 1980-05-15 | Yamamoto Noyaku Kk | Method of preventing useless unproductive growth, over- running of vine, and over-luxuriant growth |
US4463025A (en) * | 1980-07-22 | 1984-07-31 | The Procter & Gamble Company | Process for preparing a citrus fruit juice concentrate |
JPS5944313A (ja) * | 1982-09-07 | 1984-03-12 | Yakult Honsha Co Ltd | 抗菌性組成物 |
US4793991A (en) * | 1986-01-31 | 1988-12-27 | Slimak Karen M | Hypoallergenic cosmetics, lip balms and lip sticks |
FR2617848B1 (fr) * | 1987-07-10 | 1990-01-05 | Guyomarch Sa Ets | Polysaccharides extraits, notamment, de vegetaux utiles comme medicaments et additifs alimentaires |
US4966051A (en) * | 1987-12-28 | 1990-10-30 | Casio Computer Co., Ltd. | Effect tone generating apparatus |
US5268467A (en) * | 1988-05-23 | 1993-12-07 | Verbiscar Anthony J | Immunomodulatory polysaccharide fractions from Astragalus plants |
WO1990004333A1 (fr) * | 1988-09-05 | 1990-05-03 | Institut National De La Recherche Agronomique (Inra) | Procede de traitement de produits riches en parois vegetales notamment riches en pectines, lesdites pectines, les residus d'extraction du procede, leur utilisation et compositions les contenant |
US5061497A (en) * | 1989-09-11 | 1991-10-29 | Clovis Grain Processing, Ltd. | Process for the co-production of ethanol and an improved human food product from cereal grains |
US5415861A (en) * | 1991-07-01 | 1995-05-16 | Avon Products, Inc. | Composition and method for visibly reducing the size of skin pores |
US5213836A (en) * | 1991-09-18 | 1993-05-25 | American Crystal Sugar Company | Method of preparation of sugar beet fiber material |
US5431927A (en) * | 1992-06-16 | 1995-07-11 | Colgate-Palmolive Company | Pet food product having oral care properties |
US5288491A (en) * | 1992-09-24 | 1994-02-22 | Herbert Moniz | Noni (Morinda Citrifolia) as a pharmaceutical product |
US5370876A (en) * | 1993-01-08 | 1994-12-06 | Microbarriers | Antimicrobial protective skin composition and method for protecting skin from body fluids |
US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
US5503825A (en) * | 1994-01-10 | 1996-04-02 | Lane; Barry | Lip balm composition |
US5736174A (en) * | 1994-03-14 | 1998-04-07 | Arco Chemical Technology, L.P. | Alkoxylated alcohol fat substitutes |
US5616569A (en) * | 1994-03-28 | 1997-04-01 | The Iams Company | Pet food product containing fermentable fibers and process for treating gastrointestinal disorders |
JPH08217686A (ja) * | 1995-02-08 | 1996-08-27 | Terumo Corp | モリンダ・シトリフォリアの乾燥根の抽出物を含有する抗ヘリコバクター・ピロリ薬 |
US5717860A (en) * | 1995-09-20 | 1998-02-10 | Infonautics Corporation | Method and apparatus for tracking the navigation path of a user on the world wide web |
US5843499A (en) * | 1995-12-08 | 1998-12-01 | The United States Of America As Represented By The Secretary Of Agriculture | Corn fiber oil its preparation and use |
US5962043A (en) * | 1996-02-29 | 1999-10-05 | Seal Rock Technologies Incorporated | Weight reduction method for dogs and other pets |
US5776441A (en) * | 1996-08-30 | 1998-07-07 | Avon Products, Inc. | Lip treatment containing live yeast cell derivative |
US6086910A (en) * | 1997-09-19 | 2000-07-11 | The Howard Foundation | Food supplements |
US5744187A (en) * | 1996-12-16 | 1998-04-28 | Gaynor; Mitchel L. | Nutritional powder composition |
GB9704904D0 (en) * | 1997-03-10 | 1997-04-30 | Riley Fletcher Foundation The | Essential oil composition |
US6133323A (en) * | 1997-04-09 | 2000-10-17 | The Iams Company | Process for enhancing immune response in animals using β-carotene as a dietary supplement |
US5851573A (en) * | 1997-04-29 | 1998-12-22 | The Iams Company | Pet food composition for large breed puppies and method for promoting proper skeletal growth |
US6136301A (en) * | 1997-05-30 | 2000-10-24 | E-L Management Corp. | Lipid mix for lip product |
US6029141A (en) * | 1997-06-27 | 2000-02-22 | Amazon.Com, Inc. | Internet-based customer referral system |
US5922766A (en) * | 1997-07-02 | 1999-07-13 | Acosta; Phyllis J. B. | Palatable elemental medical food |
US5770217A (en) * | 1997-07-02 | 1998-06-23 | Atlatl, Inc. | Dietary supplement for hematological, immune and appetite enhancement |
FR2765799B1 (fr) * | 1997-07-08 | 1999-08-27 | Oreal | Composition brillante contenant des huiles aromatiques epaissies par un alkylether de polysaccharide |
US6405948B1 (en) * | 1997-07-18 | 2002-06-18 | Pulsewave Llc | Liberating intracellular matter from biological material |
IN187860B (ja) * | 1997-08-27 | 2002-07-06 | Revlon Consumer Prod Corp | |
US6039952A (en) * | 1997-10-22 | 2000-03-21 | The Iams Company | Composition and method for improving clinical signs in animals with renal disease |
US6139897A (en) * | 1998-03-24 | 2000-10-31 | Kao Corporation | Oil or fat composition containing phytosterol |
US5976549A (en) * | 1998-07-17 | 1999-11-02 | Lewandowski; Joan | Method to reduce bad breath in a pet by administering raw garlic |
US6156355A (en) * | 1998-11-02 | 2000-12-05 | Star-Kist Foods, Inc. | Breed-specific canine food formulations |
US6299925B1 (en) * | 1999-06-29 | 2001-10-09 | Xel Herbaceuticals, Inc. | Effervescent green tea extract formulation |
US6254913B1 (en) * | 1999-08-27 | 2001-07-03 | Morinda, Inc. | Morinda citrifolia dietary fiber and method |
US6214351B1 (en) * | 1999-08-27 | 2001-04-10 | Morinda, Inc. | Morinda citrifolia oil |
US6261566B1 (en) * | 1999-10-22 | 2001-07-17 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic compositions containing mulberry extract and retinoids |
US6291533B1 (en) * | 1999-12-22 | 2001-09-18 | Vitamerica, Inc. | Dietary supplements for each specific blood type |
US6477509B1 (en) * | 2000-01-06 | 2002-11-05 | Efunz.Com | Internet marketing method and system |
US6436449B2 (en) * | 2000-03-02 | 2002-08-20 | Bo Gidlund | Use of a composition |
US6387370B1 (en) * | 2001-01-19 | 2002-05-14 | A. Glenn Braswell | Compositions containing extracts of Morinda citrifolia, red wine, prune, blueberry, pomegranate, apple and enzyme mixture |
US7014873B2 (en) * | 2001-11-14 | 2006-03-21 | Morinda, Inc. | Method and formulation for treating candidiasis using morinda citrifolia |
-
2003
- 2003-05-16 US US10/439,596 patent/US7048952B2/en not_active Expired - Fee Related
- 2003-05-21 JP JP2004506834A patent/JP2006516019A/ja active Pending
- 2003-05-21 EP EP03729043A patent/EP1505996A1/en not_active Withdrawn
- 2003-05-21 CA CA002486606A patent/CA2486606A1/en not_active Abandoned
- 2003-05-21 AU AU2003233606A patent/AU2003233606A1/en not_active Abandoned
- 2003-05-21 WO PCT/US2003/015912 patent/WO2003099310A1/en active Application Filing
-
2006
- 2006-03-31 US US11/394,675 patent/US20070087066A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030225005A1 (en) | 2003-12-04 |
WO2003099310A1 (en) | 2003-12-04 |
AU2003233606A1 (en) | 2003-12-12 |
CA2486606A1 (en) | 2003-12-04 |
US20070087066A1 (en) | 2007-04-19 |
US7048952B2 (en) | 2006-05-23 |
EP1505996A1 (en) | 2005-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7048952B2 (en) | Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice | |
US7014873B2 (en) | Method and formulation for treating candidiasis using morinda citrifolia | |
US7442395B2 (en) | Formulation for treating candidiasis using Morinda citrifolia | |
US20050202109A1 (en) | Methods and compositions for inhibiting monoamine oxidase and catechol-o-methyltransferase | |
US20070248701A1 (en) | Methods and formulations for inhibiting naturally occurring phosphodiesterase | |
US20050260291A1 (en) | Methods and compositions for reactivating acetylcholinesterase | |
US20060269631A1 (en) | Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells | |
US20030157205A1 (en) | Inhibitory and preventative effects of processed morinda citrifolia on mutagenesis and carcinogenesis in mammals | |
US20060269630A1 (en) | Morinda citrifolia as a 5-Lipoxygenase inhibitor | |
JP2006514005A (ja) | モリンダシトリフォリアの抗血管新生効果 | |
US20040191341A1 (en) | Morinda citrifolia as a 5-Lipoxygenase inhibitor | |
US20060280818A1 (en) | Nicotinic acetylcholine receptor antagonist | |
JP2007016015A (ja) | ヒストン脱アセチル化酵素および腫瘍壊死因子変換酵素阻害 | |
US8574642B2 (en) | Antiviral Morinda citrifolia L. based formulations and methods of administration | |
US8025910B2 (en) | Method and composition for administering bioactive compounds derived from Morinda citrifolia | |
US20100034905A1 (en) | Method of treating burns | |
US8535741B2 (en) | Method and composition for administering bioactive compounds derived from Morinda citrifolia | |
US20080213415A1 (en) | Treatment of Glaucoma and Diabetic Retinopathy with Morinda Citrifolia Enhanced Formulations | |
US20090011057A1 (en) | Formulations and methods for inhibiting anaerobes, gram negative bacteria, protozoa and other microbial growth with morinda citrifolia l. enhanced formulations | |
AU2004320518B2 (en) | Morinda citrifolia-based formulation 5-LOX and 15-LOX | |
US20070281903A1 (en) | Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX | |
AU2008201790A1 (en) | Morinda Citrifolia-Based Formulation 5-Lox and 15-Lox |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A072 | Dismissal of procedure [no reply to invitation to correct request for examination] |
Free format text: JAPANESE INTERMEDIATE CODE: A072 Effective date: 20060314 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081028 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090127 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090512 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20091020 |